The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People

NCT04476745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-09

No results posted yet for this study

Summary

The effect of Weekly 50,000 IU vitamin D3 supplements on the serum levels of selected cytokines involved in cytokine storm of Covid-19; A randomized clinical trial in the Covid-19 uninfected people with vitamin D deficiency.

Conditions

  • Cytokine Storm

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Dietary Supplement: Vitamin D3 (50,000) IU / week for 8 weeks

Sponsors & Collaborators

  • Applied Science Private University

    lead OTHER

Principal Investigators

  • Mahmoud S Abu-Samak, PhD · Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan

  • Dana A Bader, MSc · Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2021-03-22
Completion
2021-04-15

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04476745 on ClinicalTrials.gov